---
schema_version: "secwatch.filing_event.v1"
accession: "0001839882-23-026088"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T06:52:06.963376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharmaceuticals prices $4.5M public offering of common stock and warrants

## Summary
- Offering comprises 9M shares, 9M Series A warrants (5-yr, $0.50 exercise), 9M Series B warrants (1-yr, $0.50); combined price $0.50 per unit.
- Gross proceeds ~$4.5M; net proceeds for working capital, manufacturing & R&D facilities, and product acquisition/licensing.
- Placement agents A.G.P./Alliance Global Partners and Brookline Capital Markets; 7.0% cash fee plus up to $100k expense reimbursement.
- Closing expected on or about October 3, 2023, subject to customary closing conditions.
- Directors and officers subject to 60-day lock-up on sale of securities post-closing.

## SEC filing metadata
- accession: 0001839882-23-026088
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/tnxp-8k_092823.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001839882-23-026088
- JSON: https://secwatch.observer/filing/0001839882-23-026088.json
- Plain text: https://secwatch.observer/filing/0001839882-23-026088.txt

## Key facts
- Material Agreements
  Tonix Pharmaceuticals Holding Corp. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (effective 2023-09-28).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC
  - Effective: 2023-09-28
  source text: On September 28, 2023, the Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the “Placement Agents”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm
- Material Agreements
  Tonix Pharmaceuticals Holding Corp. entered into Securities Purchase Agreement with certain institutional investors valued at approximately $4.5 million (effective 2023-09-28).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $4.5 million
  - Effective: 2023-09-28
  source text: On September 28, 2023, Tonix Pharmaceuticals Holding Corp. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Purchasers”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.